Global and United States Alpha Thalassemia Treatment Market Report & Forecast 2024-2031

Report ID: 1822948 | Published Date: Jan 2025 | No. of Page: 87 | Base Year: 2024 | Rating: 4.2 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Study Coverage
    1.1 Alpha Thalassemia Treatment Revenue in Alpha Thalassemia Treatment Business (2017-2022) & (US$ Million) Introduction
    1.2 Global Alpha Thalassemia Treatment Outlook 2017 VS 2022 VS 2028
        1.2.1 Global Alpha Thalassemia Treatment Market Size for the Year 2017-2028
        1.2.2 Global Alpha Thalassemia Treatment Market Size for the Year 2017-2028
    1.3 Alpha Thalassemia Treatment Market Size, United States VS Global, 2017 VS 2022 VS 2028
        1.3.1 The Market Share of United States Alpha Thalassemia Treatment in Global, 2017 VS 2022 VS 2028
        1.3.2 The Growth Rate of Alpha Thalassemia Treatment Market Size, United States VS Global, 2017 VS 2022 VS 2028
    1.4 Alpha Thalassemia Treatment Market Dynamics
        1.4.1 Alpha Thalassemia Treatment Industry Trends
        1.4.2 Alpha Thalassemia Treatment Market Drivers
        1.4.3 Alpha Thalassemia Treatment Market Challenges
        1.4.4 Alpha Thalassemia Treatment Market Restraints
    1.5 Study Objectives
    1.6 Years Considered
2 Alpha Thalassemia Treatment by Type
    2.1 Alpha Thalassemia Treatment Market Segment by Type
        2.1.1 Folic Acid
        2.1.2 Deferasirox
        2.1.3 Deferiprone
        2.1.4 Hydroxyurea
    2.2 Global Alpha Thalassemia Treatment Market Size by Type (2017, 2022 & 2028)
    2.3 Global Alpha Thalassemia Treatment Market Size by Type (2017-2028)
    2.4 United States Alpha Thalassemia Treatment Market Size by Type (2017, 2022 & 2028)
    2.5 United States Alpha Thalassemia Treatment Market Size by Type (2017-2028)
3 Alpha Thalassemia Treatment by Application
    3.1 Alpha Thalassemia Treatment Market Segment by Application
        3.1.1 Hospitals
        3.1.2 Ambulatory Surgical Centers
        3.1.3 Others
    3.2 Global Alpha Thalassemia Treatment Market Size by Application (2017, 2022 & 2028)
    3.3 Global Alpha Thalassemia Treatment Market Size by Application (2017-2028)
    3.4 United States Alpha Thalassemia Treatment Market Size by Application (2017, 2022 & 2028)
    3.5 United States Alpha Thalassemia Treatment Market Size by Application (2017-2028)
4 Global Alpha Thalassemia Treatment Competitor Landscape by Company
    4.1 Global Alpha Thalassemia Treatment Market Size by Company
        4.1.1 Top Global Alpha Thalassemia Treatment Companies Ranked by Revenue (2021)
        4.1.2 Global Alpha Thalassemia Treatment Revenue by Player (2017-2022)
    4.2 Global Alpha Thalassemia Treatment Concentration Ratio (CR)
        4.2.1 Alpha Thalassemia Treatment Market Concentration Ratio (CR) (2017-2022)
        4.2.2 Global Top 5 and Top 10 Largest Companies of Alpha Thalassemia Treatment in 2021
        4.2.3 Global Alpha Thalassemia Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    4.3 Global Alpha Thalassemia Treatment Headquarters, Revenue in Alpha Thalassemia Treatment Business (2017-2022) & (US$ Million) Type
        4.3.1 Global Alpha Thalassemia Treatment Headquarters and Area Served
        4.3.2 Global Alpha Thalassemia Treatment Companies Revenue in Alpha Thalassemia Treatment Business (2017-2022) & (US$ Million) Type
        4.3.3 Date of International Companies Enter into Alpha Thalassemia Treatment Market
    4.4 Companies Mergers & Acquisitions, Expansion Plans
    4.5 United States Alpha Thalassemia Treatment Market Size by Company
        4.5.1 Top Alpha Thalassemia Treatment Players in United States, Ranked by Revenue (2021)
        4.5.2 United States Alpha Thalassemia Treatment Revenue by Players (2020, 2021 & 2022)
5 Global Alpha Thalassemia Treatment Market Size by Region
    5.1 Global Alpha Thalassemia Treatment Market Size by Region: 2017 VS 2022 VS 2028
    5.2 Global Alpha Thalassemia Treatment Market Size by Region (2017-2028)
        5.2.1 Global Alpha Thalassemia Treatment Market Size by Region: 2017-2022
        5.2.2 Global Alpha Thalassemia Treatment Market Size by Region (2023-2028)
6 Segment in Region Level & Country Level
    6.1 North America
        6.1.1 North America Alpha Thalassemia Treatment Market Size YoY Growth 2017-2028
        6.1.2 North America Alpha Thalassemia Treatment Market Facts & Figures by Country (2017, 2022 & 2028)
        6.1.3 U.S.
        6.1.4 Canada
    6.2 Asia-Pacific
        6.2.1 Asia-Pacific Alpha Thalassemia Treatment Market Size YoY Growth 2017-2028
        6.2.2 Asia-Pacific Alpha Thalassemia Treatment Market Facts & Figures by Region (2017, 2022 & 2028)
        6.2.3 China
        6.2.4 Japan
        6.2.5 South Korea
        6.2.6 India
        6.2.7 Australia
        6.2.8 Taiwan
        6.2.9 Indonesia
        6.2.10 Thailand
        6.2.11 Malaysia
        6.2.12 Philippines
    6.3 Europe
        6.3.1 Europe Alpha Thalassemia Treatment Market Size YoY Growth 2017-2028
        6.3.2 Europe Alpha Thalassemia Treatment Market Facts & Figures by Country (2017, 2022 & 2028)
        6.3.3 Germany
        6.3.4 France
        6.3.5 U.K.
        6.3.6 Italy
        6.3.7 Russia
    6.4 Latin America
        6.4.1 Latin America Alpha Thalassemia Treatment Market Size YoY Growth 2017-2028
        6.4.2 Latin America Alpha Thalassemia Treatment Market Facts & Figures by Country (2017, 2022 & 2028)
        6.4.3 Mexico
        6.4.4 Brazil
        6.4.5 Argentina
    6.5 Middle East and Africa
        6.5.1 Middle East and Africa Alpha Thalassemia Treatment Market Size YoY Growth 2017-2028
        6.5.2 Middle East and Africa Alpha Thalassemia Treatment Market Facts & Figures by Country (2017, 2022 & 2028)
        6.5.3 Turkey
        6.5.4 Saudi Arabia
        6.5.5 U.A.E
7 Company Profiles
    7.1 GlaxoSmithKline
        7.1.1 GlaxoSmithKline Company Details
        7.1.2 GlaxoSmithKline Business Overview
        7.1.3 GlaxoSmithKline Alpha Thalassemia Treatment Introduction
        7.1.4 GlaxoSmithKline Revenue in Alpha Thalassemia Treatment Business (2017-2022)
        7.1.5 GlaxoSmithKline Recent Development
    7.2 Novartis AG
        7.2.1 Novartis AG Company Details
        7.2.2 Novartis AG Business Overview
        7.2.3 Novartis AG Alpha Thalassemia Treatment Introduction
        7.2.4 Novartis AG Revenue in Alpha Thalassemia Treatment Business (2017-2022)
        7.2.5 Novartis AG Recent Development
    7.3 Bellicum Pharmaceuticals
        7.3.1 Bellicum Pharmaceuticals Company Details
        7.3.2 Bellicum Pharmaceuticals Business Overview
        7.3.3 Bellicum Pharmaceuticals Alpha Thalassemia Treatment Introduction
        7.3.4 Bellicum Pharmaceuticals Revenue in Alpha Thalassemia Treatment Business (2017-2022)
        7.3.5 Bellicum Pharmaceuticals Recent Development
    7.4 Acceleron Pharma
        7.4.1 Acceleron Pharma Company Details
        7.4.2 Acceleron Pharma Business Overview
        7.4.3 Acceleron Pharma Alpha Thalassemia Treatment Introduction
        7.4.4 Acceleron Pharma Revenue in Alpha Thalassemia Treatment Business (2017-2022)
        7.4.5 Acceleron Pharma Recent Development
    7.5 Johnson & Johnson
        7.5.1 Johnson & Johnson Company Details
        7.5.2 Johnson & Johnson Business Overview
        7.5.3 Johnson & Johnson Alpha Thalassemia Treatment Introduction
        7.5.4 Johnson & Johnson Revenue in Alpha Thalassemia Treatment Business (2017-2022)
        7.5.5 Johnson & Johnson Recent Development
    7.6 Merck & Co.
        7.6.1 Merck & Co. Company Details
        7.6.2 Merck & Co. Business Overview
        7.6.3 Merck & Co. Alpha Thalassemia Treatment Introduction
        7.6.4 Merck & Co. Revenue in Alpha Thalassemia Treatment Business (2017-2022)
        7.6.5 Merck & Co. Recent Development
    7.7 Gilead Sciences, Inc.
        7.7.1 Gilead Sciences, Inc. Company Details
        7.7.2 Gilead Sciences, Inc. Business Overview
        7.7.3 Gilead Sciences, Inc. Alpha Thalassemia Treatment Introduction
        7.7.4 Gilead Sciences, Inc. Revenue in Alpha Thalassemia Treatment Business (2017-2022)
        7.7.5 Gilead Sciences, Inc. Recent Development
8 Research Findings and Conclusion
9 Appendix
    9.1 Research Methodology
        9.1.1 Methodology/Research Approach
        9.1.2 Data Source
    9.2 Author Details
    9.3 Disclaimer

List of Tables
    Table 1. Alpha Thalassemia Treatment Market Size United States VS Global, CAGR (2017 VS 2022 VS 2028)
    Table 2. Alpha Thalassemia Treatment Market Trends
    Table 3. Alpha Thalassemia Treatment Market Drivers
    Table 4. Alpha Thalassemia Treatment Market Challenges
    Table 5. Alpha Thalassemia Treatment Market Restraints
    Table 6. Global Alpha Thalassemia Treatment Market Size by Type: 2017 VS 2022 VS 2028 (US$ Million)
    Table 7. United States Alpha Thalassemia Treatment Market Size by Type: 2017 VS 2022 VS 2028 (US$ Million)
    Table 8. Global Alpha Thalassemia Treatment Market Size by Application: 2017 VS 2022 VS 2028 (US$ Million)
    Table 9. United States Alpha Thalassemia Treatment Market Size by Application: 2017 VS 2022 VS 2028 (US$ Million)
    Table 10. Top Alpha Thalassemia Treatment Companies in Global Market, Ranking by Revenue (2021)
    Table 11. Global Alpha Thalassemia Treatment Revenue by Player, (US$ Million), 2017-2022
    Table 12. Global Alpha Thalassemia Treatment Revenue Share by Player, 2017-2022
    Table 13. Global Alpha Thalassemia Treatment Companies Market Concentration Ratio (CR5 and HHI)
    Table 14. Global Alpha Thalassemia Treatment by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Alpha Thalassemia Treatment as of 2021)
    Table 15. Top Players of Alpha Thalassemia Treatment in Global Market, Headquarters and Area Served
    Table 16. Companies Revenue in Alpha Thalassemia Treatment Business (2017-2022) & (US$ Million) Type
    Table 17. Date of International Companies Enter into Alpha Thalassemia Treatment Market
    Table 18. Companies Mergers & Acquisitions, Expansion Plans
    Table 19. Top Alpha Thalassemia Treatment Players in United States Market, Ranking by Revenue (2021)
    Table 20. United States Alpha Thalassemia Treatment Revenue by Players, (US$ Million), 2020, 2021 & 2022
    Table 21. United States Alpha Thalassemia Treatment Revenue Share by Players, 2020, 2021 & 2022
    Table 22. Global Alpha Thalassemia Treatment Market Size by Region (US$ Million): 2017 VS 2022 VS 2028
    Table 23. Global Alpha Thalassemia Treatment Market Size by Region (2017-2022) & (US$ Million)
    Table 24. Global Alpha Thalassemia Treatment Market Size Forecast by Region (2023-2028) & (US$ Million)
    Table 25. North America Alpha Thalassemia Treatment Sales in Value by Country (2017-2028) & (US$ Million)
    Table 26. Asia Pacific Alpha Thalassemia Treatment Sales in Value by Region (2017-2028) & (US$ Million)
    Table 27. Europe Alpha Thalassemia Treatment Sales in Value by Country (2017-2028) & (US$ Million)
    Table 28. Latin Americaa Alpha Thalassemia Treatment Sales in Value by Country (2017-2028) & (US$ Million)
    Table 29. Middle East and Africa Alpha Thalassemia Treatment Sales in Value by Country (2017-2028) & (US$ Million)
    Table 30. GlaxoSmithKline Company Details
    Table 31. GlaxoSmithKline Business Overview
    Table 32. GlaxoSmithKline Alpha Thalassemia Treatment Product
    Table 33. GlaxoSmithKline Revenue in Alpha Thalassemia Treatment Business (2017-2022) & (US$ Million)
    Table 34. GlaxoSmithKline Recent Development
    Table 35. Novartis AG Company Details
    Table 36. Novartis AG Business Overview
    Table 37. Novartis AG Alpha Thalassemia Treatment Product
    Table 38. Novartis AG Revenue in Alpha Thalassemia Treatment Business (2017-2022) & (US$ Million)
    Table 39. Novartis AG Recent Development
    Table 40. Bellicum Pharmaceuticals Company Details
    Table 41. Bellicum Pharmaceuticals Business Overview
    Table 42. Bellicum Pharmaceuticals Alpha Thalassemia Treatment Product
    Table 43. Bellicum Pharmaceuticals Revenue in Alpha Thalassemia Treatment Business (2017-2022) & (US$ Million)
    Table 44. Bellicum Pharmaceuticals Recent Development
    Table 45. Acceleron Pharma Company Details
    Table 46. Acceleron Pharma Business Overview
    Table 47. Acceleron Pharma Alpha Thalassemia Treatment Product
    Table 48. Acceleron Pharma Revenue in Alpha Thalassemia Treatment Business (2017-2022) & (US$ Million)
    Table 49. Acceleron Pharma Recent Development
    Table 50. Johnson & Johnson Company Details
    Table 51. Johnson & Johnson Business Overview
    Table 52. Johnson & Johnson Alpha Thalassemia Treatment Product
    Table 53. Johnson & Johnson Revenue in Alpha Thalassemia Treatment Business (2017-2022) & (US$ Million)
    Table 54. Johnson & Johnson Recent Development
    Table 55. Merck & Co. Company Details
    Table 56. Merck & Co. Business Overview
    Table 57. Merck & Co. Alpha Thalassemia Treatment Product
    Table 58. Merck & Co. Revenue in Alpha Thalassemia Treatment Business (2017-2022) & (US$ Million)
    Table 59. Merck & Co. Recent Development
    Table 60. Gilead Sciences, Inc. Company Details
    Table 61. Gilead Sciences, Inc. Business Overview
    Table 62. Gilead Sciences, Inc. Alpha Thalassemia Treatment Product
    Table 63. Gilead Sciences, Inc. Revenue in Alpha Thalassemia Treatment Business (2017-2022) & (US$ Million)
    Table 64. Gilead Sciences, Inc. Recent Development
    Table 65. Research Programs/Design for This Report
    Table 66. Key Data Information from Secondary Sources
    Table 67. Key Data Information from Primary Sources
List of Figures
    Figure 1. Alpha Thalassemia Treatment Product Picture
    Figure 2. Global Alpha Thalassemia Treatment Market Size, (US$ Million), 2017 VS 2022 VS 2028
    Figure 3. Global Alpha Thalassemia Treatment Market Size 2017-2028 (US$ Million)
    Figure 4. United States Alpha Thalassemia Treatment Market Size, (US$ Million), 2017 VS 2022 VS 2028
    Figure 5. United States Alpha Thalassemia Treatment Market Size 2017-2028 (US$ Million)
    Figure 6. United States Alpha Thalassemia Treatment Market Share in Global 2017-2028
    Figure 7. Alpha Thalassemia Treatment Report Years Considered
    Figure 8. Product Picture of Folic Acid
    Figure 9. Product Picture of Deferasirox
    Figure 10. Product Picture of Deferiprone
    Figure 11. Product Picture of Hydroxyurea
    Figure 12. Global Alpha Thalassemia Treatment Market Share by Type in 2022 & 2028
    Figure 13. Global Alpha Thalassemia Treatment Market Size by Type (2017-2028) & (US$ Million)
    Figure 14. Global Alpha Thalassemia Treatment Market Share by Type (2017-2028)
    Figure 15. United States Alpha Thalassemia Treatment Market Share by Type in 2022 & 2028
    Figure 16. United States Alpha Thalassemia Treatment Market Size by Type (2017-2028) & (US$ Million)
    Figure 17. United States Alpha Thalassemia Treatment Market Share by Type (2017-2028)
    Figure 18. Product Picture of Hospitals
    Figure 19. Product Picture of Ambulatory Surgical Centers
    Figure 20. Product Picture of Others
    Figure 21. Global Alpha Thalassemia Treatment Market Share by Application in 2022 & 2028
    Figure 22. Global Alpha Thalassemia Treatment Market Size by Application (2017-2028) & (US$ Million)
    Figure 23. Global Alpha Thalassemia Treatment Market Share by Application (2017-2028)
    Figure 24. United States Alpha Thalassemia Treatment Market Share by Application in 2022 & 2028
    Figure 25. United States Alpha Thalassemia Treatment Market Size by Application (2017-2028) & (US$ Million)
    Figure 26. United States Alpha Thalassemia Treatment Market Share by Application (2017-2028)
    Figure 27. North America Alpha Thalassemia Treatment Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 28. U.S. Alpha Thalassemia Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 29. Canada Alpha Thalassemia Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 30. Europe Alpha Thalassemia Treatment Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 31. Germany Alpha Thalassemia Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 32. France Alpha Thalassemia Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 33. U.K. Alpha Thalassemia Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 34. Italy Alpha Thalassemia Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 35. Russia Alpha Thalassemia Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 36. Asia-Pacific Alpha Thalassemia Treatment Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 37. China Alpha Thalassemia Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 38. Japan Alpha Thalassemia Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 39. South Korea Alpha Thalassemia Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 40. India Alpha Thalassemia Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 41. Australia Alpha Thalassemia Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 42. Taiwan Alpha Thalassemia Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 43. Indonesia Alpha Thalassemia Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 44. Thailand Alpha Thalassemia Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 45. Malaysia Alpha Thalassemia Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 46. Philippines Alpha Thalassemia Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 47. Latin America Alpha Thalassemia Treatment Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 48. Mexico Alpha Thalassemia Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 49. Brazil Alpha Thalassemia Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 50. Argentina Alpha Thalassemia Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 51. Middle East & Africa Alpha Thalassemia Treatment Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 52. Turkey Alpha Thalassemia Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 53. Saudi Arabia Alpha Thalassemia Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 54. U.A.E Alpha Thalassemia Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 55. GlaxoSmithKline Revenue Growth Rate in Alpha Thalassemia Treatment Business (2017-2022)
    Figure 56. Novartis AG Revenue Growth Rate in Alpha Thalassemia Treatment Business (2017-2022)
    Figure 57. Bellicum Pharmaceuticals Revenue Growth Rate in Alpha Thalassemia Treatment Business (2017-2022)
    Figure 58. Acceleron Pharma Revenue Growth Rate in Alpha Thalassemia Treatment Business (2017-2022)
    Figure 59. Johnson & Johnson Revenue Growth Rate in Alpha Thalassemia Treatment Business (2017-2022)
    Figure 60. Merck & Co. Revenue Growth Rate in Alpha Thalassemia Treatment Business (2017-2022)
    Figure 61. Gilead Sciences, Inc. Revenue Growth Rate in Alpha Thalassemia Treatment Business (2017-2022)
    Figure 62. Bottom-up and Top-down Approaches for This Report
    Figure 63. Data Triangulation
    Figure 64. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
GlaxoSmithKline
Novartis AG
Bellicum Pharmaceuticals
Acceleron Pharma
Johnson & Johnson
Merck & Co.
Gilead Sciences, Inc.
Frequently Asked Questions
Alpha Thalassemia Treatment report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Alpha Thalassemia Treatment report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Alpha Thalassemia Treatment report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports

EPrison

EPrison market is segmented by region (country), players, by Type and by Application. Players, st ... Read More